Manager, FPA

Reporting to the Head of Financial Planning & Analysis, CARGO Therapeutics is hiring a Manager of FP&A.
This individual will drive efficient and effective financial operations within the FP&A team.
They will also be instrumental in building CARGO’s decision support capability to enable efficient operations and effective capital allocation across the enterprise.
Core responsibilities for the role will include ownership of accrual process and associated models for key vendors, variance analysis on financial results and forecasts, and management of planning models and data.
The role is based in San Carlos, CA.
WHAT YOU’LL DO AT CARGO THERAPEUTICS Analyze financial results on a monthly and quarterly basis in partnership with functional leadership and Accounting team to provide actionable insights on CARGO’s ongoing business Support clinical trial accruals, including review of Contract Research Organization (CRO) reports, patient costs incurred, and site payments Support manufacturing accruals, including review of Contract Development and Manufacturing Organization (CDMO) reports, costs incurred, and payments Ensure and maintain proper documentation and internal controls for SOX compliance Support the annual audit and quarterly reviews through the preparation of audit schedules and other documentation as requested by external auditors Work with CROs, CDMOs and other vendors to ensure that expenses are accurately accounted for Review contracts and amendments to analyze and determine various financial impacts Review purchase requests against budgeted amount and for account coding Support preparation of financial reporting to investors and the CARGO Board of Directors Contribute to the development of the Company’s financial and corporate strategy Embody the collaborative, innovative, and disciplined culture of the CARGO Finance team! THE RIGHT STUFF: Required Experience & Qualifications Bachelor’s degree in Finance or Accounting or equivalent work experience; MBA degree and/or CPA preferred 5+ years of experience in finance and/or accounting positions in a relevant industry setting (biotech, life sciences) Track record of collaboration, stakeholder relationship management, and influencing key decision-makers Experience with R&D accruals Well-developed analytical skills that demonstrate the ability to drive from data to analysis to insight Self-motivated with the strong work ethic and sense of urgency required for success in a rapidly growing biotech company and an equally critical ability to problem solve in high pressure situations Process-oriented thinker with experience in process design, implementation, and improvement Strong written and oral communication skills allowing for presentation of complex financial concepts in a digestible manner to stakeholders with varying degrees of financial experience Demonstrated intellectual curiosity in the life sciences industry Highly skilled in use of information technology (e.
g.
, ERP and financial planning systems) Solid working knowledge of GAAP to facilitate understanding of financial results and forward-looking forecasts Familiarity with the control and compliance requirements of a public company including knowledge of the Sarbanes-Oxley Act (SOX) PAY RANGE The combined pay range for this role is $124,000 - $170,000.
Title and salary will be based on our assessment of skills and experience relevant to our needs for the role.
ABOUT CARGO THERAPEUTICS CARGO Therapeutics, Inc.
is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients.
CARGO’s programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved cell therapies, including limited durability of effect, safety concerns and unreliable supply.
CARGO is currently evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy.
CARGO also plans to evaluate CRG-022 in patients at earlier stages of disease, including LBCL and other hematologic malignancies.
Beyond its lead program, CARGO is leveraging its proprietary cell engineering platform technologies to develop a pipeline of programs that incorporate multiple transgene therapeutic “cargo” designed to enhance CAR T-cell persistence and trafficking to tumor lesions, as well as to help safeguard against tumor resistance and T-cell exhaustion.
CARGO’s founders are pioneers and world-class experts in CAR T-cell therapy, and its team has significant experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products.
For more information, please visit the CARGO Therapeutics website at https://cargo-tx.
com/.
Join us to help make a difference! EEO & EMPLOYMENT ELIGIBILITY CARGO Therapeutics, Inc.
is committed to building a diverse, equitable, and inclusive company.
We provide equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability, or veteran status.
CARGO Therapeutics, Inc.
also complies with all applicable national, state, and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification required of applicable law.
CARGO Therapeutics requires all new hires to be fully vaccinated against COVID-19 as of their start date.
This requirement is a condition of employment at CARGO Therapeutics, and it applies regardless of whether the position is located at a CARGO Therapeutics site or is fully remote.
If you are unable to receive the vaccine due to a disability or serious medical condition, or because it is prohibited because of your sincerely held religious beliefs, you will have an opportunity to request a reasonable accommodation.